Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

69.48
-0.4100-0.59%
Post-market: 70.050.5700+0.82%19:54 EDT
Volume:20.13M
Turnover:1.40B
Market Cap:103.00B
PE:35.81
High:70.65
Open:69.77
Low:69.38
Close:69.89
52wk High:109.50
52wk Low:67.56
Shares:1.48B
Float Shares:1.48B
Volume Ratio:1.84
T/O Rate:1.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.94
EPS(LYR):1.94
ROE:12.45%
ROA:5.98%
PB:4.25
PE(LYR):35.81

Loading ...

Abbott Laboratories' Structural Heart Business Could See Upside From Watchman Trial Results, UBS Says

MT Newswires Live
·
Mar 13

Elutia Q4 revenue rises on higher cardiovascular product sales

Reuters
·
Mar 12

Boston Scientific Is Maintained at Buy by Citigroup

Dow Jones
·
Mar 11

Boston Scientific price target lowered to $94 from $102 at Citi

TIPRANKS
·
Mar 11

Baird Adjusts Price Target on Boston Scientific to $95 From $101, Maintains Outperform Rating

MT Newswires Live
·
Mar 11

U.S. RESEARCH ROUNDUP-Howmet Aerospace, Nike, Oracle

Reuters
·
Mar 11

Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 11

Boston Scientific Targets Drug-Resistant Motor Epilepsy With New Deep Brain Stimulation Trial

TIPRANKS
·
Mar 11

Boston Scientific (BSX): CHAMPION AF Trial Poised to Strengthen Watchman Evidence, Broaden Adoption, and Support Buy Rating

TIPRANKS
·
Mar 09

Class Action Lawsuit Targets Boston Scientific Over Alleged Investor Harm

Reuters
·
Mar 09

Boston Scientific’s ENTRUST Registry Targets Real-World Edge in Carotid Stroke Prevention

TIPRANKS
·
Mar 07

**Boston Scientific to webcast investor event at ACC Scientific Session**Boston Scientific will host an investor event and live webcast to discuss key clinical data presented at the 75th Annual Scientific Session of the American College of Cardiology. The webcast and replay will be available at https://investors.bostonscientific.com

Reuters
·
Mar 06

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Mar 06

Boston Scientific targets net-zero greenhouse gas emissions by 2050 and 50% emissions cuts by 2030

Reuters
·
Mar 04

Boston Scientific call volume above normal and directionally bullish

TIPRANKS
·
Mar 04

Portnoy Law Firm Investigates Boston Scientific for Possible Securities Fraud

Reuters
·
Mar 04

China Merchants Initiates Boston Scientific at Buy With $88 Price Target

MT Newswires Live
·
Mar 04

Boston Scientific: Near-Term EP Reset but 2027 Growth Drivers Support Buy Rating

TIPRANKS
·
Mar 04

Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future

Simply Wall St.
·
Mar 04

Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 04